 |
 |
 |
|
|
|
     |
| ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãß°èÇмú´ëȸ | 2014.10.27 | ||
ÀÛ¼ºÀÚ  °ü¸®ÀÚ |
Á¶È¸¼ö 1058 |
||
´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãß°èÇмú´ëȸ
ÀϽà : 2014. 10.25 Àå¼Ò : 63ÄÁº¥¼Ç¼¾ÅÍ
2014³âµµ ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãß°è ½ÉÆ÷Áö¾ö
13:30-13:40 Àλ縻 ±¸È«È¸ ÀÌ»çÀå(¼º±Õ°üÀÇ´ë) Session I. ´Ù±â°ü Àӻ󿬱¸(K-COG) ÁÂÀå: ±¸È«È¸(¼º±Õ°üÀÇ´ë) 13:40-13:50 K-COG ¼Ò°³ ¼º±â¿õ(¼º±Õ°üÀÇ´ë) 13:50-14:20 Design and Analysis of Phase II Cancer Clinical Trials Á¤½ÅÈ£(¼º±Õ°üÀÇ´ë) 14:20-14:40 2014 COG ¹ÌÆà ¼Ò°³ À±Á¾Çü(±¹¸³¾Ï¼¾ÅÍ) Session II. ¿¬±¸ Á¦¾È: Hematologic diseases ÁÂÀå: À̱¤Ã¶(°í·ÁÀÇ´ë) 14:40-15:40 1. Acute lymphoblastic leukemia ¹Ú°æ´ö(¼¿ïÀÇ´ë) 2. Lymphoma Á¤³«±Õ(°¡Å縯ÀÇ´ë) 3. Myeloid leukemia À¯°ÇÈñ(¼º±Õ°üÀÇ´ë) 4. Bone marrow failure syndrome ±¹ ÈÆ(Àü³²ÀÇ´ë) 5. Benign hematologic disease Á¤Çý¸²(¼º±Õ°üÀÇ´ë) 6. Haploidentical stem cell transplantation ÀÓÈ£ÁØ(¿ï»êÀÇ´ë) 15:40-16:00 Coffee Break | |||
|
| |||
|
